Opioid receptor binding characteristics of the non-equilibrium μ antagonist, β-funaltrexamine (β-FNA)
- 1 January 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 107 (3), 323-330
- https://doi.org/10.1016/0014-2999(85)90257-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Pharmacological profiles of β-funaltrexamine (β-FNA) and β-chlornaltrexamine (β-CNA) on the mouse vas deferens preparationEuropean Journal of Pharmacology, 1982
- CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAINBritish Journal of Pharmacology, 1981
- Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brainEuropean Journal of Pharmacology, 1981
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- The Role of Membrane Lipids in Receptor MechanismsAnnual Review of Pharmacology and Toxicology, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- Stereospecific binding of etorphine in isolated neural cells and in retina determined by a sensitive microassayBrain Research, 1976
- ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEYBritish Journal of Pharmacology, 1975
- A New Concept on the Mode of Interaction of Narcotic Analgesics with ReceptorsJournal of Medicinal Chemistry, 1965